Literature DB >> 34355218

New Potential Options for SBRT in Pancreatic Cancer.

Maged Ghaly1, Emile Gogineni1, Joseph Herman1, Muhammad W Saif1.   

Abstract

Stereotactic body radiotherapy (SBRT) is an emerging treatment option for patients with pancreatic cancer, as it can provide a therapeutic benefit with significant advantages for patients' quality of life over standard conventional chemoradiation (CRT). The objective of this review is to present alternative clinical settings in which SBRT may benefit patients with pancreatic cancer. These include palliation of pain, elderly patients who are not surgical candidates, local therapy in oligometastatic cases and salvaging local failures after surgery or external beam radiation. We will review these individually and provide supporting literature for each.

Entities:  

Keywords:  Pancreas cancer; Pancreatic neoplasms; Radiation; Radiosurgery; Radiotherapy; Stereotactic; Stereotactic body radiation therapy (SBRT)

Year:  2021        PMID： 34355218      PMCID： PMC8336074     

Source DB:  PubMed          Journal:  Cancer Med J


  53 in total

1.  Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer.

Authors:  Joseph J Park; Carla Hajj; Marsha Reyngold; Weiji Shi; Zhigang Zhang; John J Cuaron; Christopher H Crane; Eileen M O'Reilly; Maeve A Lowery; Kenneth H Yu; Karyn A Goodman; Abraham J Wu
Journal:  Acta Oncol       Date:  2017-06-29       Impact factor: 4.089

2.  Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity.

Authors:  Erqi L Pollom; Muthuraman Alagappan; Rie von Eyben; Pamela L Kunz; George A Fisher; James A Ford; George A Poultsides; Brendan C Visser; Jeffrey A Norton; Aya Kamaya; Veronica L Cox; Laurie A Columbo; Albert C Koong; Daniel T Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-10-18       Impact factor: 7.038

3.  Pain relief after a short course of palliative radiotherapy in pancreatic cancer, the Academic Medical Center (AMC) experience.

Authors:  Gati Ebrahimi; Coen R N Rasch; Geertjan van Tienhoven
Journal:  Acta Oncol       Date:  2017-11-20       Impact factor: 4.089

4.  Effect of low-dose gemcitabine on unresectable pancreatic cancer in elderly patients.

Authors:  Kazuyuki Matsumoto; Yasuhiro Miyake; Hironari Kato; Hirofumi Kawamoto; Atsushi Imagawa; Tatsuya Toyokawa; Morihito Nakatsu; Masaharu Ando; Mamoru Hirohata; Kazuhide Yamamoto
Journal:  Digestion       Date:  2011-08-23       Impact factor: 3.216

5.  Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.

Authors:  Aaron T Wild; Susan M Hiniker; Daniel T Chang; Phuoc T Tran; Mouen A Khashab; Maneesha R Limaye; Daniel A Laheru; Dung T Le; Rachit Kumar; Jonathan S Pai; Blaire Hargens; Andrew B Sharabi; Eun Ji Shin; Lei Zheng; Timothy M Pawlik; Christopher L Wolfgang; Albert C Koong; Joseph M Herman
Journal:  J Gastrointest Oncol       Date:  2013-12

6.  Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer.

Authors:  Aaron T Wild; Joseph M Herman; Avani S Dholakia; Shalini Moningi; Yao Lu; Lauren M Rosati; Amy Hacker-Prietz; Ryan K Assadi; Ali M Saeed; Timothy M Pawlik; Elizabeth M Jaffee; Daniel A Laheru; Phuoc T Tran; Matthew J Weiss; Christopher L Wolfgang; Eric Ford; Stuart A Grossman; Xiaobu Ye; Susannah G Ellsworth
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-12-01       Impact factor: 7.038

7.  Stereotactic body radiation therapy for liver metastases from colorectal cancer: analysis of safety, feasibility, and early outcomes.

Authors:  Marie-Adele S Kress; Brian T Collins; Sean P Collins; Anatoly Dritschilo; Gregory Gagnon; Keith Unger
Journal:  Front Oncol       Date:  2012-02-02       Impact factor: 6.244

8.  Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer.

Authors:  Nergiz Dagoglu; Mark Callery; James Moser; Jennifer Tseng; Tara Kent; Andrea Bullock; Rebecca Miksad; Joseph D Mancias; Anand Mahadevan
Journal:  J Cancer       Date:  2016-01-10       Impact factor: 4.207

Review 9.  Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief.

Authors:  Milly Buwenge; Gabriella Macchia; Alessandra Arcelli; Rezarta Frakulli; Lorenzo Fuccio; Sara Guerri; Elisa Grassi; Silvia Cammelli; Francesco Cellini; Alessio G Morganti
Journal:  J Pain Res       Date:  2018-10-04       Impact factor: 3.133

10.  Stereotactic body radiation therapy for locally advanced pancreatic cancer.

Authors:  Jinhong Jung; Sang Min Yoon; Jin-Hong Park; Dong-Wan Seo; Sang Soo Lee; Myung-Hwan Kim; Sung Koo Lee; Do Hyun Park; Tae Jun Song; Baek-Yeol Ryoo; Heung-Moon Chang; Kyu-Pyo Kim; Changhoon Yoo; Jae Ho Jeong; Song Cheol Kim; Dae Wook Hwang; Jae Hoon Lee; Ki Byung Song; Yoon Young Jo; Jongmoo Park; Jong Hoon Kim
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240
View more
  2 in total

Review 1.  Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer.

Authors:  Garett J Steers; Gloria Y Chen; Brianne R O'Leary; Juan Du; Hannah Van Beek; Joseph J Cullen
Journal:  Antioxidants (Basel)       Date:  2022-05-14

Review 2.  Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies.

Authors:  Alaa Y Bazeed; Candace M Day; Sanjay Garg
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.